Clark Ian T. - 19 Dec 2025 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Shane Kovacs, Attorney-in-fact
Issuer symbol
OLMA
Transactions as of
19 Dec 2025
Net transactions value
-$6,653,566
Form type
4
Filing time
23 Dec 2025, 21:42:34 UTC
Previous filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CLARK IAN T Director C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN STREET, SAN FRANCISCO /s/ Shane Kovacs, Attorney-in-fact 23 Dec 2025 0001336504

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Options Exercise $923,894 +209,690 $4.41 209,690 19 Dec 2025 Direct
transaction OLMA Common Stock Options Exercise $77,687 +21,520 +10% $3.61 231,210 19 Dec 2025 Direct
transaction OLMA Common Stock Options Exercise $168,717 +21,520 +9.3% $7.84 252,730 19 Dec 2025 Direct
transaction OLMA Common Stock Options Exercise $49,246 +12,070 +4.8% $4.08 264,800 19 Dec 2025 Direct
transaction OLMA Common Stock Sale $862,132 -29,904 -11% $28.83 234,896 19 Dec 2025 Direct F1
transaction OLMA Common Stock Sale $5,735,694 -193,056 -82% $29.71 41,840 19 Dec 2025 Direct F2
transaction OLMA Common Stock Sale $1,275,283 -41,840 -100% $30.48 0 19 Dec 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -209,690 -100% $0.000000 0 19 Dec 2025 Common Stock 209,690 $4.41 Direct F4
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -21,520 -100% $0.000000 0 19 Dec 2025 Common Stock 21,520 $3.61 Direct F4
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -21,520 -100% $0.000000 0 19 Dec 2025 Common Stock 21,520 $7.84 Direct F4
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -12,070 -50% $0.000000 12,080 19 Dec 2025 Common Stock 12,070 $4.08 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $28.83, and the range of prices was between $28.215 and $29.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F2 The weighted average sale price for the transaction reported was $29.71, and the range of prices was between $29.22 and $30.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F3 The weighted average sale price for the transaction reported was $30.48, and the range of prices was between $30.23 and $30.995. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4 Fully vested.
F5 The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 11, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.